Dr. Chedid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Victor Chedid is a gastroenterologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 6 years. He also speaks multiple languages, including Arabic and French. He specializes in anorectal function & pelvic floor dysfunction, gastrointestinal functional & motility disorders, and inflammatory bowel disease and is experienced in irritable bowel syndrome, inflammatory bowel disease, ulcerative colitis, crohn's disease, and gastrointestinal motility disorders.
Education & Training
- Mayo Clinic Graduate SchoolMaster of Science, Clinical and Translational Science , 2016 - 2020
- Mayo Clinic College of Medicine and ScienceFellowship, Inflammatory Bowel Disease, 2019 - 2019
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2016 - 2019
- UPMC Medical EducationResidency, Internal Medicine, 2013 - 2016
- American University of Beirut Faculty of MedicineClass of 2010
- American University of BeirutBS, Biology, 2003 - 2006
Certifications & Licensure
- AZ State Medical License 2022 - 2025
- MN State Medical License 2016 - 2025
- PA State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Gold Foundation Humanism and Excellence in Teaching University of Pittsburgh Medical School, 2016
- Poster of Distinction - Digestive Disease Week 2015
- Outstanding Senior Resident Teaching Award University of Pittsburgh, 2015
- Join now to see all
Clinical Trials
- Does Welchol (Colesevelam Hydrochloride) Improve Colonic Transit in Diarrhea-predominant Irritable Bowel Syndrome (D-IBS)? Start of enrollment: 2009 Jan 01
- Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity Start of enrollment: 2015 Dec 18
- Dermatome Electrical Stimulation on Individuals With Overweight and Class I Obesity Start of enrollment: 2017 Feb 21
- Join now to see all
Publications & Presentations
PubMed
- Orofacial Granulomatosis and Crohn's Disease: A Case Series.Siri A Urquhart, Grace Y Kim, Katelyn R Anderson, Victor G Chedid
ACG Case Reports Journal. 2024-11-01 - Disparities in pain management among transgender patients presenting to the emergency department for abdominal pain.Kellyn Engstrom, Fernanda Bellolio, Molly Moore Jeffery, Sara C Sutherland, Kayla P Carpenter
Academic Emergency Medicine. 2024-10-03 - Building a Cancer Care Clinic for Transgender and Gender Diverse Individuals.Elizabeth J Cathcart-Rake, Amye Tevaarwerk, Aminah Jatoi, Evelyn F Carroll, Nfn Scout
Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2024-10-01
Journal Articles
- Hematemesis in a 67 Year Old MaleJangouk P, Chedid V, Hashash JG, J Clin Case Rep
Books/Book Chapters
Abstracts/Posters
- P-019 YI Risk Factors for Suicidality Amongst Depressed IBD PatientsVachon A, Altman L, Hashash J, Fabio A, Chedid V, Williams C, Rivers C, Thorkelson G, Binion D, Regueiro M, Szigethy E, Inflammatory Bowel Diseases, 1/1/2016
- Predictors of Suicidal Severity Amongst Suicidal IBD PatientsHashash J, Vachon A, Altman L, Chedid V, Fabio A, Williams C, Rivers C, Regueiro M, Binion D, Szigethy E, Inflammatory Bowel Diseases, 1/1/2016
- Granulomatous Hepatitis as a consequence of disseminated Mycobacterium bovisChedid V, Grau TC, Hashash JG, ACG 2015 Annual Scientific Meeting, Honolulu, HI, 1/1/2015
- Join now to see all
Authored Content
- The Effect of Race in Patients with Achalasia Diagnosed with High-Resolution Esophageal Manometry☆November 2017
Press Mentions
- HMN 2024: What Is Inflammatory Bowel Disease?December 2nd, 2024
- Mayo Clinic Minute: What Is Inflammatory Bowel Disease?May 17th, 2024
- Randomised Study: Effects of the 5‐HT4 Receptor Agonist Felcisetrag vs Placebo on Gut Transit in Patients with GastroparesisMarch 12th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Crohn's and Colitis Foundation of AmericaMember
- Rainbows in GastroMember
Other Languages
- Arabic, French
External Links
- Mayo Clinic Biohttps://www.mayoclinic.org/biographies/chedid-victor-g-m-d/bio-20478657
- LinkedIn https://www.linkedin.com/in/victor-chedid-a9596a169
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: